“To his credit, Duggan is willing to back an effort in an area (new antibiotics) that most big-money investors and companies are too scared to enter.”

—Forbes, February 27, 2020,
“Billionaire Robert Duggan’s New Biotech Chapter: An Antibiotics Quest”